148 related articles for article (PubMed ID: 27378313)
1. Renin-Angiotensin System Inhibitors vs Other Antihypertensives in Hypertensive Blacks: A Meta-Analysis.
Palla M; Ando T; Androulakis E; Telila T; Briasoulis A
J Clin Hypertens (Greenwich); 2017 Apr; 19(4):344-350. PubMed ID: 27378313
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care.
Haroon S; Subramanian A; Cooper J; Anand A; Gokhale K; Byne N; Dhalla S; Acosta-Mena D; Taverner T; Okoth K; Wang J; Chandan JS; Sainsbury C; Zemedikun DT; Thomas GN; Parekh D; Marshall T; Sapey E; Adderley NJ; Nirantharakumar K
BMC Infect Dis; 2021 Mar; 21(1):262. PubMed ID: 33722197
[TBL] [Abstract][Full Text] [Related]
3. Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity.
Brewster LM; van Montfrans GA; Oehlers GP; Seedat YK
Intern Emerg Med; 2016 Apr; 11(3):355-74. PubMed ID: 27026378
[TBL] [Abstract][Full Text] [Related]
4. Role of antihypertensive medicines in prostate cancer: a systematic review.
Iheanacho CO; Enechukwu OH
BMC Cancer; 2024 Apr; 24(1):542. PubMed ID: 38684963
[TBL] [Abstract][Full Text] [Related]
5. The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.
Gómez-Acebo I; Dierssen-Sotos T; Palazuelos C; Pérez-Gómez B; Lope V; Tusquets I; Alonso MH; Moreno V; Amiano P; Molina de la Torre AJ; Barricarte A; Tardon A; Camacho A; Peiro-Perez R; Marcos-Gragera R; Muñoz M; Michelena-Echeveste MJ; Ortega Valin L; Guevara M; Castaño-Vinyals G; Aragonés N; Kogevinas M; Pollán M; Llorca J
PLoS One; 2016; 11(8):e0159672. PubMed ID: 27508297
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Research Progress of Novel Antihypertensive Drugs.
Huang L; Zhang Y; Xing L; Li PQ; Chu HQ; He CX; Qin W; Cao HL
Discov Med; 2024 May; 36(184):882-897. PubMed ID: 38798249
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers and renin-angiotensin system inhibitors for Takotsubo syndrome recurrence: a network meta-analysis.
Santoro F; Sharkey S; Citro R; Miura T; Arcari L; Urbano-Moral JA; Stiermaier T; Nuñez-Gil IJ; Silverio A; Di Nunno N; Ragnatela I; Cetera R; Nishida J; Eitel I; Brunetti ND
Heart; 2024 Mar; 110(7):476-481. PubMed ID: 37666647
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation vs. continuation of renin-angiotensin system inhibition before non-cardiac surgery: the SPACE trial.
Ackland GL; Patel A; Abbott TEF; Begum S; Dias P; Crane DR; Somanath S; Middleditch A; Cleland S; Gutierrez Del Arroyo A; Brealey D; Pearse RM;
Eur Heart J; 2024 Apr; 45(13):1146-1155. PubMed ID: 37935833
[TBL] [Abstract][Full Text] [Related]
9. Association of antihypertensives and Parkinson's disease in a primary care population matched for underlying diagnosis.
Schrag A; Kostev K
PLoS One; 2024; 19(3):e0299985. PubMed ID: 38507360
[TBL] [Abstract][Full Text] [Related]
10. β-blockers as the First Line of Treatment for Hypertension Management.
Ray S; Banshi S; Shashank J; Mangesh T; Sandeep B; Kumar K; Baishali N
J Assoc Physicians India; 2023 Sep; 71(9):95-100. PubMed ID: 38700308
[TBL] [Abstract][Full Text] [Related]
11. Hypertension in the postpartum woman: clinical update for the hypertension specialist.
Ghuman N; Rheiner J; Tendler BE; White WB
J Clin Hypertens (Greenwich); 2009 Dec; 11(12):726-33. PubMed ID: 20021530
[TBL] [Abstract][Full Text] [Related]
12. Renin Angiotensin system-modifying therapies are associated with improved pulmonary health.
Soto M; Bang SI; McCombs J; Rodgers KE
Clin Diabetes Endocrinol; 2017; 3():6. PubMed ID: 28702260
[TBL] [Abstract][Full Text] [Related]
13. Management of Essential Hypertension.
Ferdinand KC; Nasser SA
Cardiol Clin; 2017 May; 35(2):231-246. PubMed ID: 28411897
[TBL] [Abstract][Full Text] [Related]
14. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
[TBL] [Abstract][Full Text] [Related]
15. African American Veterans Storytelling: A Multisite Randomized Trial to Improve Hypertension.
Houston TK; Fix GM; Shimada SL; Long JA; Gordon HS; Pope C; Volkman J; Allison JJ; DeLaughter K; Orner M; Bokhour BG
Med Care; 2017 Sep; 55 Suppl 9 Suppl 2():S50-S58. PubMed ID: 28806366
[TBL] [Abstract][Full Text] [Related]
16. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
Suchard MA; Schuemie MJ; Krumholz HM; You SC; Chen R; Pratt N; Reich CG; Duke J; Madigan D; Hripcsak G; Ryan PB
Lancet; 2019 Nov; 394(10211):1816-1826. PubMed ID: 31668726
[TBL] [Abstract][Full Text] [Related]
18. A Review of ACE Inhibitors and ARBs in Black Patients With Hypertension.
Helmer A; Slater N; Smithgall S
Ann Pharmacother; 2018 Nov; 52(11):1143-1151. PubMed ID: 29808707
[TBL] [Abstract][Full Text] [Related]
19. First-line drugs for hypertension.
Wright JM; Musini VM; Gill R
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD001841. PubMed ID: 29667175
[TBL] [Abstract][Full Text] [Related]
20. Outpatient management of essential hypertension: a review based on the latest clinical guidelines.
Moiz A; Zolotarova T; Eisenberg MJ
Ann Med; 2024 Dec; 56(1):2338242. PubMed ID: 38604225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
